Skip to main content

Table 2 Observed and expected numbers of complications in six NTCP groups

From: Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer

NTCP range

No. of patients

Observed Complications

Expected Complications

0.05-0.075

11

2

1

0.075-0.10

19

3

2

0.10-0.125

18

3

2

0.125-0.15

25

2

4

0.15-0.175

27

4

4

0.175-0.25

15

1

3